Terms: = Leukemia AND IGH AND Clinical Outcome
20 results:
1. Non-IG::MYC in diffuse large B-cell lymphoma confers variable genomic configurations and MYC transactivation potential.
Zhang C; Stelloo E; Barrans S; Cucco F; Jiang D; Tzioni MM; Chen Z; Li Y; Swennenhuis JF; Makker J; Rásó-Barnett L; Liu H; El-Daly H; Soilleux E; Shah N; Nagumantry SK; Kyaw M; Prahladan MP; Tooze R; Westhead DR; Feitsma H; Davies AJ; Burton C; Johnson PWM; Du MQ
Leukemia; 2024 Mar; 38(3):621-629. PubMed ID: 38184753
[TBL] [Abstract] [Full Text] [Related]
2. Targeted locus amplification to detect molecular markers in mantle cell and follicular lymphoma.
Genuardi E; Klous P; Mantoan B; Drandi D; Ferrante M; Cavallo F; Alessandria B; Dogliotti I; Grimaldi D; Ragaini S; Clerico M; Lo Schirico M; Saraci E; Yilmaz M; Zaccaria GM; Cortelazzo S; Vitolo U; Luminari S; Federico M; Boccadoro M; van Min M; Splinter E; Ladetto M; Ferrero S
Hematol Oncol; 2021 Aug; 39(3):293-303. PubMed ID: 33742718
[TBL] [Abstract] [Full Text] [Related]
3. Early relapse after complete remission of primary plasma cell leukaemia manifesting clonal evolution: A case report.
Nyunt WWT; Abdul Jalil D; Zakariah NA; Abdul Karim N; Mohd Idris MR; Nasuruddin DN; Salwati SHUIB; Alauddin H; Tumian NR; Leong CF; Abdul Wahid SFS
Malays J Pathol; 2020 Apr; 42(1):143-150. PubMed ID: 32342945
[TBL] [Abstract] [Full Text] [Related]
4. Conventional and molecular cytogenetic characterization of Burkitt lymphoma with bone marrow involvement in Brazilian children and adolescents.
De Souza MT; Hassan R; Liehr T; Marques-Salles TJ; Boulhosa AM; Abdelhay E; Ribeiro RC; Silva ML
Pediatr Blood Cancer; 2014 Aug; 61(8):1422-6. PubMed ID: 24668946
[TBL] [Abstract] [Full Text] [Related]
5. Validation of Western common recurrent chromosomal aberrations in Korean chronic lymphocytic leukaemia patients with very low incidence.
Yoon JH; Kim Y; Yahng SA; Shin SH; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Kim HJ; Min CK; Kim DW; Lee JW; Min WS; Park CW; Lim J; Kim Y; Han K; Kim M; Cho SG
Hematol Oncol; 2014 Dec; 32(4):169-77. PubMed ID: 24123081
[TBL] [Abstract] [Full Text] [Related]
6. The prognostic impact of clinical and molecular features in hairy cell leukaemia variant and splenic marginal zone lymphoma.
Hockley SL; Else M; Morilla A; Wotherspoon A; Dearden C; Catovsky D; Gonzalez D; Matutes E
Br J Haematol; 2012 Aug; 158(3):347-54. PubMed ID: 22594855
[TBL] [Abstract] [Full Text] [Related]
7. Splenic marginal zone lymphoma: characterization of 7q deletion and its value in diagnosis.
Watkins AJ; Huang Y; Ye H; Chanudet E; Johnson N; Hamoudi R; Liu H; Dong G; Attygalle A; McPhail ED; Law ME; Isaacson PG; de Leval L; Wotherspoon A; Du MQ
J Pathol; 2010 Mar; 220(4):461-74. PubMed ID: 20077527
[TBL] [Abstract] [Full Text] [Related]
8. Clinicopathological features of lymphoma/leukemia patients carrying both BCL2 and MYC translocations.
Tomita N; Tokunaka M; Nakamura N; Takeuchi K; Koike J; Motomura S; Miyamoto K; Kikuchi A; Hyo R; Yakushijin Y; Masaki Y; Fujii S; Hayashi T; Ishigatsubo Y; Miura I
Haematologica; 2009 Jul; 94(7):935-43. PubMed ID: 19535347
[TBL] [Abstract] [Full Text] [Related]
9. Immunoglobulin diversity gene usage predicts unfavorable outcome in a subset of chronic lymphocytic leukemia patients.
Tschumper RC; Geyer SM; Campbell ME; Kay NE; Shanafelt TD; Zent CS; Nowakowski GS; Call TG; Dewald GW; Jelinek DF
J Clin Invest; 2008 Jan; 118(1):306-15. PubMed ID: 18064298
[TBL] [Abstract] [Full Text] [Related]
10. Immunoglobulin gene segment usage, location and immunogenicity in mutated and unmutated chronic lymphocytic leukaemia.
Mauerer K; Zahrieh D; Gorgun G; Li A; Zhou J; Ansén S; Rassenti LZ; Gribben JG
Br J Haematol; 2005 May; 129(4):499-510. PubMed ID: 15877732
[TBL] [Abstract] [Full Text] [Related]
11. Utilization of Ig heavy chain variable, diversity, and joining gene segments in children with B-lineage acute lymphoblastic leukemia: implications for the mechanisms of VDJ recombination and for pathogenesis.
Li A; Rue M; Zhou J; Wang H; Goldwasser MA; Neuberg D; Dalton V; Zuckerman D; Lyons C; Silverman LB; Sallan SE; Gribben JG;
Blood; 2004 Jun; 103(12):4602-9. PubMed ID: 15010366
[TBL] [Abstract] [Full Text] [Related]
12. Loss of heterozygosity of p16 correlates with minimal residual disease at the end of the induction therapy in non-high risk childhood B-cell precursor acute lymphoblastic leukemia.
Tutor O; Díaz MA; Ramírez M; Algara P; Madero L; Martínez P
Leuk Res; 2002 Sep; 26(9):817-20. PubMed ID: 12127556
[TBL] [Abstract] [Full Text] [Related]
13. Residual disease detection using fluorescent polymerase chain reaction at 20 weeks of therapy predicts clinical outcome in childhood acute lymphoblastic leukemia.
Evans PA; Short MA; Owen RG; Jack AS; Forsyth PD; Shiach CR; Kinsey S; Morgan GJ
J Clin Oncol; 1998 Nov; 16(11):3616-27. PubMed ID: 9817283
[TBL] [Abstract] [Full Text] [Related]
14. Minimal residual disease analysis for the prediction of relapse in children with standard-risk acute lymphoblastic leukaemia.
Goulden NJ; Knechtli CJ; Garland RJ; Langlands K; Hancock JP; Potter MN; Steward CG; Oakhill A
Br J Haematol; 1998 Jan; 100(1):235-44. PubMed ID: 9450818
[TBL] [Abstract] [Full Text] [Related]
15. clinical relevance of T-cell receptor delta gene rearrangements in childhood B-precursor cell acute lymphoblastic leukaemia.
Díaz MA; Garcia-Sanchez F; Vicario JL; Ramirez M; Balas A; Madero L
Br J Haematol; 1997 Nov; 99(2):308-13. PubMed ID: 9375746
[TBL] [Abstract] [Full Text] [Related]
16. Determination of clonality in patients who present with diagnostic dilemmas: a laboratory experience and review of the literature.
Rockman SP
Leukemia; 1997 Jun; 11(6):852-62. PubMed ID: 9177440
[TBL] [Abstract] [Full Text] [Related]
17. PCR-positivity in harvested bone marrow predicts relapse after transplantation with autologous purged bone marrow in children in second remission of precursor B-cell acute leukaemia.
Vervoordeldonk SF; Merle PA; Behrendt H; Steenbergen EJ; van den Berg H; van Wering ER; von dem Borne AE; van der Schoot CE; van Leeuwen EF; Slaper-Cortenbach IC
Br J Haematol; 1997 Feb; 96(2):395-402. PubMed ID: 9029032
[TBL] [Abstract] [Full Text] [Related]
18. Long-term follow-up of residual disease in acute lymphoblastic leukemia patients in complete remission using clonogeneic igh probes and the polymerase chain reaction.
Nizet Y; Van Daele S; Lewalle P; Vaerman JL; Philippe M; Vermylen C; Cornu G; Ferrant A; Michaux JL; Martiat P
Blood; 1993 Sep; 82(5):1618-25. PubMed ID: 8364210
[TBL] [Abstract] [Full Text] [Related]
19. The significance of detection of minimal residual disease in childhood acute lymphoblastic leukaemia.
Potter MN; Steward CG; Oakhill A
Br J Haematol; 1993 Mar; 83(3):412-8. PubMed ID: 8485046
[TBL] [Abstract] [Full Text] [Related]
20. Unique genotypic features of infant acute lymphoblastic leukaemia at presentation and at relapse.
Biondi A; Rossi V; di Celle PF; Carbone A; Benvestito S; Busca A; Giudici G; Giachino C; Basso G; Foa R
Br J Haematol; 1992 Apr; 80(4):472-9. PubMed ID: 1316141
[TBL] [Abstract] [Full Text] [Related]
